Skye Bioscience, Common Stock Price on December 3, 2024
| SKYE Stock | USD 2.46 0.20 7.52% |
Below is the normalized historical share price chart for Skye Bioscience, Common extending back to November 26, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Skye Bioscience, stands at 2.46, as last reported on the 29th of December, with the highest price reaching 2.68 and the lowest price hitting 2.38 during the day.
If you're considering investing in Skye Stock, it is important to understand the factors that can impact its price. Skye Bioscience, Common owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.12, which indicates the firm had a -0.12% return per unit of risk over the last 3 months. Skye Bioscience, Common exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Skye Bioscience,'s Coefficient Of Variation of (872.30), risk adjusted performance of (0.08), and Variance of 24.72 to confirm the risk estimate we provide.
At present, Skye Bioscience,'s Issuance Of Capital Stock is projected to increase significantly based on the last few years of reporting. . The current year's Price Earnings To Growth Ratio is expected to grow to 0.01, whereas Price To Sales Ratio is forecasted to decline to 274.83. Skye Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 2nd of April 2015 | 200 Day MA 8.3529 | 50 Day MA 4.8512 | Beta 1.75 |
Skye |
Sharpe Ratio = -0.1207
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SKYE |
Estimated Market Risk
| 4.97 actual daily | 44 56% of assets are more volatile |
Expected Return
| -0.6 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Skye Bioscience, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Skye Bioscience, by adding Skye Bioscience, to a well-diversified portfolio.
Price Book 0.9846 | Book Value 2.499 | Enterprise Value 7.4 M | Enterprise Value Ebitda (2.56) | Shares Float 17.4 M |
Related Headline
Tonix Pharmaceuticals Headline on 3rd of December 2024
TNXP NDA Filed for TNX-102 SL in Fibromyalgia by finance.yahoo.com
By David Bautz, PhD NASDAQTNXP READ THE FULL TNXP RESEARCH REPORT Business Update NDA Filed for TNX-102 SL in Fibromyalgia On October 16, 2024, Tonix Pharmaceuticals Holding Corp. announced that it had filed the New Drug Application for TNX-102 SL for the treatment of fibromyalgia. The FDA typically has a 60-day window to determine if the submitted NDA is acceptable for
Skye Bioscience, Valuation on December 3, 2024
It is possible to determine the worth of Skye Bioscience, on a given historical date. On December 3, 2024 Skye was worth 4.29 at the beginning of the trading date compared to the closed value of 4.41. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Skye Bioscience, stock. Still, in general, we apply an absolute valuation method to find Skye Bioscience,'s value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Skye Bioscience, where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Skye Bioscience,'s related companies.
| Open | High | Low | Close | Volume | |
| 4.49 | 4.51 | 4.27 | 4.28 | 91,705 | |
12/03/2024 | 4.29 | 4.58 | 4.25 | 4.41 | 144,513 |
| 4.31 | 4.42 | 3.82 | 3.85 | 246,094 |
| Backtest Skye Bioscience, | | | Skye Bioscience, History | | | Skye Bioscience, Valuation | Previous | Next |
Skye Bioscience, Trading Date Momentum on December 3, 2024
| On December 04 2024 Skye Bioscience, Common was traded for 3.85 at the closing time. The top price for the day was 4.42 and the lowest listed price was 3.82 . The trading volume for the day was 246.1 K. The trading history from December 4, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 12.70% . The trading price change against the current closing price is 25.62% . |
Skye Bioscience, Common Fundamentals Correlations and Trends
By evaluating Skye Bioscience,'s financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Skye Bioscience,'s main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Skye financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Skye Bioscience, Stock history
Skye Bioscience, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Skye is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Skye Bioscience, Common will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Skye Bioscience, stock prices may prove useful in developing a viable investing in Skye Bioscience,
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 7 M | 6.7 M | |
| Net Loss | -7.7 M | -8.1 M |
Skye Bioscience, Stock Technical Analysis
Skye Bioscience, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Skye Bioscience, Period Price Range
Low | December 29, 2024
| High |
0.00 | 0.00 |
Skye Bioscience, Common cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Skye Bioscience, December 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Skye Bioscience, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Skye Bioscience, shares will generate the highest return on investment. By undertsting and applying Skye Bioscience, stock market strength indicators, traders can identify Skye Bioscience, Common entry and exit signals to maximize returns
Skye Bioscience, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Skye Bioscience,'s price direction in advance. Along with the technical and fundamental analysis of Skye Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Skye to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.59) | |||
| Total Risk Alpha | (0.72) | |||
| Treynor Ratio | (1.99) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Skye Stock analysis
When running Skye Bioscience,'s price analysis, check to measure Skye Bioscience,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Skye Bioscience, is operating at the current time. Most of Skye Bioscience,'s value examination focuses on studying past and present price action to predict the probability of Skye Bioscience,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Skye Bioscience,'s price. Additionally, you may evaluate how the addition of Skye Bioscience, to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |